paper
report
new
proteas
inhibitori
activ
plakortid
e
toward
cathepsin
cathepsinlik
parasit
proteas
report
antiparasit
activ
trypanosoma
brucei
ic
valu
without
cytotox
effect
macrophag
concentr
plakortid
e
isol
spong
plakorti
halichondroid
use
enzym
assayguid
fraction
identifi
nmr
spectroscopi
mass
spectrometri
furthermor
enzym
kinet
studi
confirm
plakortid
e
noncompetit
slowlybind
revers
inhibitor
rhodesain
proteas
enabl
breakdown
protein
via
catalyt
hydrolysi
peptid
bond
malfunct
control
proteas
activ
lead
undesir
unregul
proteolysi
caus
mani
diseas
therefor
inhibitor
proteas
potenti
provid
success
therapeut
wide
rang
diseas
marin
spong
famili
plakinida
known
rich
sourc
structur
uniqu
biolog
activ
metabolit
bioactivityguid
fraction
crude
cyclohexan
extract
spong
plakorti
halichondroid
yield
pure
endoperoxid
metabolit
name
plakortid
e
figur
previous
isol
spong
speci
plakortid
e
previous
shown
stimul
sarcoplasm
reticulum
sr
ca
atpas
activ
endoperoxid
plakortin
famili
eg
sixmemb
plakortin
dihydroplakortin
plakortid
q
plakortid
known
activ
plasmodia
fivememb
endoperoxid
plakortid
e
report
inact
work
highlight
new
antiproteas
antiparasit
activ
lyophil
materi
spong
plakorti
halichondroid
sequenti
extract
three
differ
solvent
crude
extract
test
proteas
inhibitori
activ
follow
proteas
human
cystein
proteas
cathepsin
b
l
relat
parasit
enzym
rhodesain
trypanosoma
brucei
rhodesiens
two
cystein
proteas
express
sar
coronaviru
name
sar
main
proteas
sar
papainlik
proteas
activ
crude
cyclohexan
extract
cy
fraction
use
column
chromatographi
final
purifi
hplc
yield
activ
pure
metabolit
plakortid
e
figur
purif
process
base
upon
bioactiv
result
ie
fraction
show
activ
enzym
purifi
activ
fraction
gradual
enhanc
everi
step
purif
process
except
first
cyclohexan
extract
whichshow
high
inhibit
cathepsin
b
l
figur
probabl
due
presenc
non
polar
activ
compound
pure
metabolit
plakortid
e
test
parasit
cathepsinl
like
proteas
plasmodium
falciparum
well
mammalian
serin
proteas
chymotrypsin
serin
proteas
dengu
viru
proteas
inhibit
found
cathepsin
cathepsinlik
proteas
order
studi
inhibit
mechan
plakortid
e
enzym
assay
variou
inhibitor
substrat
concentr
perform
cathepsin
b
determin
whether
inhibit
competit
respect
substrat
ic
valu
cathepsin
b
determin
three
differ
substrat
concentr
valu
almost
similar
indic
noncompetit
inhibit
cathepsin
l
ic
substrat
concentr
rhodesain
ic
substrat
concentr
determin
rhodesain
nonlinear
progress
curv
substrat
hydrolysi
observ
presenc
inhibitor
therefor
determin
timedepend
inhibit
measur
ic
valu
correl
incub
time
enzym
inhibitor
ad
prior
substrat
addit
ic
valu
decreas
longer
incub
time
min
min
min
indic
coval
inhibit
mechan
lead
slow
bind
address
whether
inhibit
revers
irrevers
kinet
studi
perform
describ
copeland
dilut
assay
perform
compar
irrevers
vinylsulfonebas
inhibitor
rhodesain
enzym
rhodesain
fold
concentr
use
normal
enzym
assay
preincub
fold
ic
concentr
compound
one
hour
allow
format
enzymeinhibitor
complex
lead
total
block
enzym
activ
complex
dilut
fold
ad
assay
buffer
substrat
thu
enzym
concentr
reduc
one
use
normal
assay
inhibitor
concentr
reduc
ic
revers
inhibitor
dissoci
complex
enzym
activ
recov
case
irrevers
inhibit
dissoci
complex
occur
enzym
activ
detect
assay
show
reactiv
enzym
case
plakortid
e
activ
contrast
enzym
activ
detect
indic
revers
inhibit
plakortid
e
summari
plakortid
e
determin
noncompetit
revers
inhibitor
cystein
proteas
case
rhodesain
slowbind
observ
furthermor
plakortid
e
test
parasit
leishmania
major
promastigot
trypomastigot
form
trypanosoma
brucei
candida
albican
also
test
cytotox
macrophag
compound
exhibit
trypanocid
activ
ic
valu
h
also
h
may
least
part
due
proteas
inhibit
properti
plakortid
e
show
activ
leishmania
also
express
varieti
cathepsinlik
proteas
activ
candida
cytotox
effect
macrophag
observ
sinc
leishmania
promastigot
form
express
less
cystein
proteas
amastigot
form
cysteineproteas
inhibit
properti
compound
may
suffici
detect
leishmanicid
activ
spong
plakorti
halichondroid
collect
scuba
dive
depth
bahama
juli
gp
spong
tissu
cut
small
piec
preserv
extract
frozen
materi
dri
lyophil
lyophil
materi
g
subsequ
macer
sequenti
extract
cyclohexan
cy
methylen
dichlorid
dcm
final
methanol
meoh
filtrat
crude
extract
concentr
reduc
pressur
crude
cyclohexan
extract
g
chromatograph
silica
gel
g
column
elut
isocrat
solvent
cyclohexanemethylen
dichloridemethanolform
acid
elut
fraction
combin
base
upon
tlc
result
yield
five
fraction
cyfr
iv
fraction
fraction
cyfr
iii
silica
gel
column
chromatographi
use
solvent
system
cyclohexanemethylen
dichlorid
increas
polar
chloroformmethanol
afford
seven
subfract
cy
ag
subfract
cy
e
subject
prepar
hplc
use
rp
column
eluent
methanolwat
formic
acid
flow
mlmin
afford
fraction
cy
n
p
fraction
cy
n
purifi
use
prepar
hplc
use
rp
column
methanolwat
amend
formic
acid
flow
mlmin
retent
time
peak
observ
min
yield
pure
bioactiv
compound
compound
identifi
plakortid
e
mean
ms
nmr
spectral
data
tabl
comparison
previous
publish
nmr
data
enzym
assay
parasit
growth
assay
perform
describ
previous
nmr
spectra
tabl
obtain
bruker
bruker
biospin
gmbh
rheinstetten
germani
typ
advanc
spectromet
mass
spectra
measur
use
bruker
microtof
mass
spectromet
column
chromatographi
perform
use
silica
gel
mm
mesh
merck
darmstadt
germani
tlc
conduct
precoat
silica
gel
plate
mm
merck
darmstadt
germani
spot
detect
use
vanillin
spray
reagent
uv
nm
iodinevapour
reagent
purchas
sigmaaldrich
munich
germani
fluka
munich
germani
solvent
purchas
roth
karlsruh
germani
merck
darmstadt
germani
high
perform
liquid
chromatographi
perform
varian
prostar
rheinfelden
schweiz
consist
analyticalprepar
hplc
upscal
linear
system
mlmin
bar
pressur
scalemast
prepar
autosampl
uv
detector
detect
wavelength
nm
nm
plakortid
e
product
obtain
colourless
viscou
oil
g
enzym
assay
vitro
test
antiparasit
activ
perform
publish
previous
cathepsinlik
cystein
proteas
see
sar
pro
see
sar
pl
pro
see
dengu
viru
proteas
see
assay
brucei
see
assay
macrophag
see
assay
l
major
promastigot
see
assay
c
albican
see
plakortid
e
obtain
marin
spong
plakorti
halichondroid
identifi
new
proteas
inhibitor
plakortid
e
show
select
toward
cathepsinlik
cystein
proteas
noncompetit
revers
case
rhodesain
slowbind
inhibitori
mode
action
antiproteas
activ
compound
may
contribut
antiparasit
activ
trypanosoma
brucei
rhodesain
also
cathepsin
b
like
proteas
tbcatb
known
essenti
parasit
growth
pathogen
